ArticleCureus2026
Atypical Overt Hemorrhagic Stroke in an Adult With Sickle Cell-Hemoglobin C Disease: A Report of a Rare Case.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sickle cell disease (SCD) is an inherited hemoglobinopathy in which deformed erythrocytes impair microvascular blood flow, leading to complications across multiple organ systems. Variants of SCD exist, and a less common form involves the inheritance of one hemoglobin S allele and one hemoglobin C allele, manifesting as sickle cell-hemoglobin C (HbSC) disease. Although HbSC disease can cause significant sequelae, a rare but serious complication is hemorrhagic stroke. In such cases, chronic endothelial injury, vascular fragility, and abnormal hemodynamics associated with this hemoglobinopathy may predispose patients to vessel rupture, resulting in hemorrhage. We report the case of a 54-year-old man with HbSC disease who was admitted for an acute sickle cell crisis and subsequently experienced an overt hemorrhagic stroke. The patient developed chronic neurological deficits and remains under skilled nursing care. This case highlights the rare occurrence of hemorrhagic stroke in HbSC disease and challenges the perception that HbSC is a benign condition.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.